Share

The Gist Healthcare Podcast
Wednesday, October 23, 2024
•
Cigna and Humana have reportedly resumed merger talks after abandoning plans late last year. Walgreens is looking at a healthcare future without VillageMD as a key component. And, Blue Cross Blue Shield will pay roughly $2.8 billion to settle a class action antitrust case brought by providers. We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare podcast.
More episodes
View all episodes

Friday, December 5, 2025
09:32|Senate Democrats introduced legislation that would extend Affordable Care Act tax credits, a proposal that could affect coverage affordability. The Trump Administration issued a revised definition of which professions qualify for higher cap federal student loans. New research also links early adolescent smartphone use to increased risks of depression, obesity, and poor sleep. Hear the full update on The Gist Healthcare Podcast.
Wednesday, December 3, 2025
07:40|The Centers for Medicare and Medicaid Services is considering updates to how it calculates Medicare Advantage star ratings. The United States and the United Kingdom have agreed to a zero percent pharmaceutical tariff. The House passes legislation to extend the hospital-at-home waiver. Hear more on today’s episode of The Gist Healthcare Podcast.
Wednesday, November 19, 2025
07:53|On today’s Gist Healthcare Podcast: Medicare Part B premiums rise 10 percent next year, the White House is in talks about extending ACA enhanced tax credits, and a federal judge signs off on Purdue Pharma’s bankruptcy plan tied to the opioid crisis.
Continuing the Conversation: Data Reveal Stronger Surgical Outcomes Across US Hospitals
13:40|Following recent improvements in surgical outcomes, hospitals are now confronting new challenges tied to patient complexity, post-acute care access, and workforce capacity. In this episode, Chris DeRienzo, MD, Senior Vice President and Chief Physician Executive for the American Hospital Association, discusses findings from the latest Vizient and AHA analysis, including how delayed discharges and administrative demands affect care delivery. The conversation also looks at what hospitals are doing to sustain safety gains amid increasing acuity and staffing pressures. You can listen to the first half of the conversation here.
Friday, November 14, 2025
08:46|On today’s Gist Healthcare Podcast: The government shutdown ends without an agreement to extend Affordable Care Act tax credits. Canada loses its measles elimination status, signaling renewed public health risks. And the Trump Administration seems likely to extend telehealth flexibilities that allow clinicians to prescribe controlled substances without an in-person visit.
Wednesday, November 12, 2025
08:39|On today’s Gist Healthcare Podcast: The Senate passes a spending bill to end the government shutdown without extending Affordable Care Act subsidies. The FDA plans to remove black box warnings from hormone replacement therapies for menopause. And UnitedHealthcare pulls back coverage for remote patient monitoring.
Data Reveal Stronger Surgical Outcomes Across US Hospitals
12:26|A new analysis from Vizient and the American Hospital Association shows that outcomes for hospitalized surgical patients have improved in recent years. In this episode, Chris DeRienzo, Senior Vice President and Chief Physician Executive for the AHA, discusses the data behind those findings and what may be contributing to the changes. The conversation looks at how hospitals are managing increasingly complex patients while maintaining gains in safety and quality.
Friday, November 7, 2025
06:15|The Trump Administration reaches a deal to lower prices on weight loss drugs, the FDA fast-tracks biosimilars, and a new report shows UnitedHealthcare pays its Optum physicians more than others. Hear the latest on The Gist Healthcare Podcast.
Wednesday, November 5, 2025
07:20|On today’s episode of The Gist Healthcare Podcast, CMS finalizes a Medicare pay bump for physicians. Kimberly-Clark to purchase Tylenol maker Kenvue, and Pfizer sues to block Novo Nordisk’s merger with an obesity startup.